Discovery Lens
C Combination Innovation
Two separate worlds finally connect — and the intersection is a product
One-Liner
Pre-funded subscription model for robotic elder care services, structured on funeral pre-need annuity financial mechanics.
AI Thinking Process
Funeral pre-need annuity: consumers pre-fund burial expenses at today's prices, protected against inflation, through licensed funeral homes. Verb Transplant: apply the same pre-funding mechanics to robotic elder care subscriptions — consumers in their 60s pre-fund 10 years of robot companionship/assistance at today's prices.
Dual adoption barrier identified: (1) Distribution channel conflict — funeral pre-need salesperson channels are structured around licensed funeral home relationships and will not promote a competing pre-fund product for the same wallet. (2) Consumer demand for home robots in 2026 is negligible — Figure, 1X, Unitree have consumer availability timelines of 2027-2029. Pre-funding a product that doesn't ship is unsellable.
KILLED: dual structural barrier. LTC insurer pivot (Genworth, Mutual of Omaha) reduces to an OEM robot broker relationship — not a software product. Pre-need verb requires established consumer demand; robot demand gap is timing, not addressable by product design.
Kill Reason
Dual structural barrier: (1) funeral pre-need sales channels will not sell a competing product competing for the same 65-year-old's wallet; (2) consumer demand for home robots does not yet exist (Figure, 1X, Unitree targeting 2027-2029). LTC insurer wholesale pivot reduces to a robot OEM broker relationship, not a software product.
Risk Analysis
Risk analysis available for latest engine ideas.
Loading...
Related ideas you can explore free:
killed: Passive voice-based depression detection requires FDA Software as a Medical Device clearance for any diagnostic claim; a "wellness" framing undercuts the core value proposition and reduces willingness to pay. Epic Systems and large telehealth platforms are already integrating validated mental health screening tools into clinical workflows, crowding out standalone apps before they achieve scale.
killed: Google Nest Hub's built-in Soli radar-based sleep sensing already delivers contactless respiratory monitoring in millions of households, and Withings has shipped FDA-cleared sleep apnea screening hardware. A standalone $30 WiFi module cannot match the distribution, brand trust, or regulatory standing of these well-resourced incumbents.
killed: Urine and stool analysis for glucose monitoring, cancer screening, and kidney function markers falls squarely into FDA Class II/III medical device territory, requiring clinical trials and 510(k) or PMA approval costing millions and taking years. The entire high-value use case — the reason anyone would buy this — is legally undeliverable without regulatory clearance the product cannot realistically obtain.